Literature DB >> 16185863

Novel and expanded jadomycins incorporating non-proteogenic amino acids.

David L Jakeman1, Cathy L Graham, Taryn R Reid.   

Abstract

Jadomycin B is a secondary metabolite produced, in response to stress, by Streptomyces venezuelae ISP5230 grown in nutrient-deprived media. We present definitive electrospray ionization mass spectrometry data identifying a series of novel jadomycins with non-proteogenic amino acids incorporated into the oxazolone ring of the secondary metabolite, and strengthening evidence for the existence of an aldimine intermediate in the biosynthetic pathway. We also demonstrate that the size of the oxazolone ring can be expanded by incorporating beta-amino acids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185863     DOI: 10.1016/j.bmcl.2005.08.047

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Culture conditions improving the production of jadomycin B.

Authors:  David L Jakeman; Cathy L Graham; Wendy Young; Leo C Vining
Journal:  J Ind Microbiol Biotechnol       Date:  2006-03-28       Impact factor: 3.346

2.  Multi-oxygenase complexes of the gilvocarcin and jadomycin biosyntheses.

Authors:  Madan K Kharel; Lili Zhu; Tao Liu; Jürgen Rohr
Journal:  J Am Chem Soc       Date:  2007-03-09       Impact factor: 15.419

3.  Antimicrobial activities of jadomycin B and structurally related analogues.

Authors:  David L Jakeman; Srinivasulu Bandi; Cathy L Graham; Taryn R Reid; Jason R Wentzell; Susan E Douglas
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

4.  Biosynthesis and Total Synthesis Studies on The Jadomycin Family of Natural Products.

Authors:  Ehesan U Sharif; George A O'Doherty
Journal:  European J Org Chem       Date:  2012-04

5.  Jadomycin breast cancer cytotoxicity is mediated by a copper-dependent, reactive oxygen species-inducing mechanism.

Authors:  Steven R Hall; Heather L Blundon; Matthew A Ladda; Andrew W Robertson; Camilo F Martinez-Farina; David L Jakeman; Kerry B Goralski
Journal:  Pharmacol Res Perspect       Date:  2015-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.